Diagnostic utility of wireless motility capsule in gastrointestinal dysmotility

Journal of Clinical Gastroenterology

Volumn 45, Issue 8, 2011, Pages 684-690

  Rao, Satish S C ^a   Mysore, Krupa ^a   Attaluri, Ashok ^a   Valestin, Jessica ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

colonic transit; constipation; gastric emptying; gastroparesis; wireless motility capsule

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; LAXATIVE; NARCOTIC AGENT; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOATING; CONSTIPATION; CONTROLLED STUDY; CONVENTIONAL MOTILITY TEST; DEFECATION DISORDER; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; EPIGASTRIC FULLNESS; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL RADIOGRAPHY; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INTESTINE; INTESTINE TRANSIT TIME; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NAUSEA; POSTPRANDIAL FULLNESS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STOMACH EMPTYING; SYMPTOM; UPPER GASTROINTESTINAL TRACT; VOMITING; WIRELESS MOTILITY CAPSULE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAPSULE ENDOSCOPY; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HUMANS; IOWA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80052028310     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181ff0122     Document Type: Article

References (32)

1. Locke GR, Zinsmeister AR, Fett SL, et al. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil. 2005;17:29-34. (Pubitemid 40204009)
2. Talley NJ, Holtmann G, Agréus L, et al. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol. 2000;95:1439-1447. (Pubitemid 30396300)
3. Talley NJ, Dennis EH, Schettler-Duncan VA, et al. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003;98:2454-2459. (Pubitemid 37448756)
4. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004;99:750-759. (Pubitemid 38612817)
5. Hungin AP, Chang L, Locke GR, et al. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther. 2005;21:1365-1375. (Pubitemid 40813683)
6. Rao SSC, Seaton K, Miller MJ, et al. Psychological profiles and quality of life (QOL) differ between patients with dyssynergia and slow transit constipation. J Psychosom Res. 2007;63:441-449. (Pubitemid 47464366)
7. Martin R, Barron JJ, Zacker C. Irritable bowel syndrome: toward a cost-effective management approach. Am J Manag Care. 2001;7(8 suppl):S268-S275. (Pubitemid 32700473)
8. Paré P, Gray J, Lam S, et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Clin Ther. 2006;28:1726-1735. (Pubitemid 44841981)
9. Singh G, Lingala V, Wang H, et al. Use of health care resources and cost of care for adults with constipation. Clin Gastroenterol Hepatol. 2007;5:1053-1058.
10. Spiegel BM. The burden of IBS: looking at metrics. Curr Gastroenterol Rep. 2009;11:265-269.
11. Longstreth GF, Wilson A, Knight K, et al. Irritable bowel syndrome, health care use, and costs: a US managed care perspective. Am J Gastroenterol. 2003;98:600-607. (Pubitemid 36348532)
12. Bratten J, Jones MP. New directions in the assessment of gastric function: clinical applications of physiologic measurements. Dig Dis. 2006;24:252-259. (Pubitemid 44114418)
13. Sarosiek I, Selover KH, Katz LA, et al. The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology. Aliment Pharmacol Ther. 2010;31:313-322.
14. Rao SS, Kuo B, McCallum RW, et al. Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol. 2009;7:537-544.
15. Drossman DA,Morris CB, Schneck S, et al. International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol. 2009;43:541-550.
16. Rao SS. Constipation: evaluation and treatment of colonic and anorectal motility disorders. Gastroenterol Clin North Am. 2007;36:687-711. (Pubitemid 47575844)
17. Khayyam U, Sachdeva P, Gomez J, et al. Assessment of symptoms during gastric emptying scintigraphy to correlate symptoms to delayed gastric emptying. Neurogastroenterol Motil. 2010;22:539-545.
18. Parkman HP, Hasler WL, Fisher RS. American gastroenterological association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1592-1622. (Pubitemid 39457783)
19. Rao SSC, Mudipalli RS, Stessman M, et al. Investigation of the utility of colorectal function tests and Rome II criteria in dyssynergic defecation (Anismus). Neurogastroenterol Motil. 2004;16:1-8.
20. Grotz RL, Pemberton JH, Talley NJ, et al. Discriminant value of psychological distress, symptom profiles, and segmental colonic dysfunction in outpatients with severe idiopathic constipation. Gut. 1994;35:798-802. (Pubitemid 24193225)
21. Camilleri M, Bharucha AE, Di Lorenzo C, et al. American neurogastroenterology and motility society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil. 2008;20:1269-1282.
22. Camilleri M, Hasler W, Parkman HP, et al. Measurement of gastroduodenal motility in the GI laboratory. Gastroenterology. 1998;115:747-762.
23. Rao SSC, Ozturk R, Laine L. Clinical utility of diagnostic test for constipation in adults: a systematic review. Am J Gastroenterol. 2005;100:1605-1615. (Pubitemid 41032371)
24. Bonapace ES, Maurer AH, Davidoff S, et al. Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am J Gastroenterol. 2000;95:2838-2847.
25. Rao SSC, Sadeghi P, Beaty J, et al. Ambulatory 24-hour colonic manometry in slow-transit constipation. Am J Gastroenterol. 2004;99:2405-2416. (Pubitemid 40039372)
26. Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000;95:1456-1462. (Pubitemid 30396302)
27. Lin HC, Prather C, Fisher RS, et al. AMS task force committee on gastrointestinal transit. Measurement of gastrointestinal transit. Dig Dis Sci. 2005;50:989-1004.
28. Kuo B, McCallum RW, Koch KL, et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharacol Ther. 2007;27:186-196. (Pubitemid 350256610)
29. Camilleri M, Thorne NK, Ringel Y, et al. Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil. 2010;22:874-882.
30. Choi YK, Kraft N, Zimmerman B, et al. Fructose intolerance in IBS and utility of fructose-restricted diet. J Clin Gastroenterol. 2008;42:233-238. (Pubitemid 351301486)
31. Hinton JM, Lennard-Jones JE, Young AC. A new method for studying gut transit times using radio-opaque markers. Gut. 1969;10:842-847.
32. Sadik R, Stotzer PO, Simren M, et al. Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre. Neurogastroenterol Motil. 2008;20:197-205. (Pubitemid 351197397)